PUBLIC HEALTH SERVICE AmendmentFirst Amendment of L-009-2021-1 • May 6th, 2024 • Curative Biotechnology Inc • Biological products, (no disgnostic substances)
Contract Type FiledMay 6th, 2024 Company IndustryThis Agreement is based on the model Amendment Agreement adopted by the US Public Health Service (“PHS”) Technology Transfer Policy Board for use by components of the National Institutes of Health (“NIH”), the Centers for Disease Control and Prevention (“CDC”), and the Food and Drug Administration (“FDA”), which are agencies of the PHS within the Department of Health and Human Services (“HHS”).